Welcome, you are not signed in yet.
Log in? New User, Register?
Registration is FREE and offers great benefits
Today is: Tue, Sep 7, 2010 | 20:17 EDT
Add our site to your favorites
Your default homepage
Home
>>
Tech Directory
>>
Lumira Capital Corp.
Business Description
Built on a foundation that leverages 18 years of North American venture capital experience, the Lumira Capital team has been investing in transformational health and life science companies for more than a decade.
Our goal: To make investments in market leading companies by working in partnership with those companies to develop strategies to generate profitable exits that maximize returns within a reasonable time frame.
Strategic business partners committed to the success of our portfolio companies, we roll up our sleeves and work side by side with our entrepreneurs and their management teams – leveraging our internal resources, knowledge networks and industry relationships along with our operational and leadership experience and deep industry expertise on their behalf.
“The team at Lumira Capital has been more than one of Pharmasset’s lead investors. Their partners worked tirelessly to ensure our success, helping us diversify our pipeline, establish a partnership with a major pharmaceutical company, attract outstanding board members, and execute a successful IPO in 2007.”
- P. Schaefer Price, MBA - CEO [NASDAQ:VRUS] Pharmasset
Tech Directory
Lumira Capital Corp.
| Last Update 2008/2/6 8:09 |
Category
VC/PE
Life Sciences
Tel Number 416.213.4223
Fax Number 416.213.4232
Life Sciences
| Headoffice | |
| 20 Bay Street, 11th Floor, Toronto, Ontario M5J 2N8 |
Built on a foundation that leverages 18 years of North American venture capital experience, the Lumira Capital team has been investing in transformational health and life science companies for more than a decade.
Our goal: To make investments in market leading companies by working in partnership with those companies to develop strategies to generate profitable exits that maximize returns within a reasonable time frame.
Strategic business partners committed to the success of our portfolio companies, we roll up our sleeves and work side by side with our entrepreneurs and their management teams – leveraging our internal resources, knowledge networks and industry relationships along with our operational and leadership experience and deep industry expertise on their behalf.
“The team at Lumira Capital has been more than one of Pharmasset’s lead investors. Their partners worked tirelessly to ensure our success, helping us diversify our pipeline, establish a partnership with a major pharmaceutical company, attract outstanding board members, and execute a successful IPO in 2007.”
- P. Schaefer Price, MBA - CEO [NASDAQ:VRUS] Pharmasset
Regional Offices
Cambridge
245 First Street , Suite 1800
Cambridge, MA, US. 02142
t.617.444.8550 f.253.484.4262
Mountain View
800 West El Camino Real , Suite 180 , Office # 21
Mountain View, CA, US. 94040
t.650.943.2448 f.650.943.2449
Montreal
1550 Metcalfe Street , Suite 502
Montreal, QC, CA. H3A 1X6
t.514.844.6927. f.514.844.5607
Executives and Directors
Mr. Peter van der Velden, President and CEO
Mr. Stephen Cummings, CFO
Ms. Graysanne Bedell, Vice President Legal
Dr. Beni Rovinski, Managing Director
Dr. Brian Underdown, Managing Director
Mr. Gerry Brunk, Managing Director
Dr. Nandini Tandon, Managing Director
Mr. Daniel Hetu, Venture Partner
Dr. Jack Jenuth, Senior Analyst
Mr. Charles Trimble, Senior Analyst
Cambridge
245 First Street , Suite 1800
Cambridge, MA, US. 02142
t.617.444.8550 f.253.484.4262
Mountain View
800 West El Camino Real , Suite 180 , Office # 21
Mountain View, CA, US. 94040
t.650.943.2448 f.650.943.2449
Montreal
1550 Metcalfe Street , Suite 502
Montreal, QC, CA. H3A 1X6
t.514.844.6927. f.514.844.5607
Executives and Directors
Mr. Peter van der Velden, President and CEO
Mr. Stephen Cummings, CFO
Ms. Graysanne Bedell, Vice President Legal
Dr. Beni Rovinski, Managing Director
Dr. Brian Underdown, Managing Director
Mr. Gerry Brunk, Managing Director
Dr. Nandini Tandon, Managing Director
Mr. Daniel Hetu, Venture Partner
Dr. Jack Jenuth, Senior Analyst
Mr. Charles Trimble, Senior Analyst
Hits: 5
Rating: 0.00 (0 votes)
Print
Tell a Friend
The comments are owned by the poster. We aren't responsible for their content.
| Poster | Thread |
|---|